Ocular Surface Syndrome Post-lasik, Outcomes of Treatment With Platelet Rich Plasma

Launched by VISSUM, INSTITUTO OFTALMOLÓGICO DE ALICANTE · Oct 23, 2017

Keywords

ClinConnect Summary

Prospective interventional consecutive case series including 156 eyes of 80 patients affected by chronic post-LASIK OSS who were treated with autologous E-PRP 6 times a day as monotherapy for 6 weeks. Assessment after treatment with E-PRP included: dry eye symptoms, change in corrected distance visual acuity (CDVA), corneal fluorescein staining (CFS) and conjunctival hyperemia.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients suffering from moderate to severe dry eye syndrome for 6 months or more after conventional treatments with artificial tears following LASIK.
• • Tear break-up time (TBUT) between 4 and 9 seconds.
• Exclusion Criteria:
• • Ocular pathology needing topical treatments different than dry eye syndrome
• • Trombocitopeny, associated pathologies to coagulation factors or any state of plaquets antiagregation (AAS and other AINES).
• • Ocular tumours, corneal distrophies, history of ocular herpes.
• • Pregnant or nursering women.